亚洲 · 区域市场 · CNBC-TV18
Aurobindo Pharma Q2 profit rises 33%, beats estimates; declares ₹7 interim dividend
Aurobindo Pharma reported a 32.8% year-on-year increase in consolidated net profit to ₹1,126 crore for the second quarter of FY27, compared with ₹848 crore in the corresponding…
在 CNBC-TV18 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.cnbctv18.com)
